Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-05

Clinical Trial Update: Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating tolerability, safety, and feasibility of naloxegol for opioid-induced constipation in cancer patients; study terminated with posted res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naloxegol (naloxegol)

Snippet

Sponsor: Hospice of Henderson County, Inc. | Conditions: Cancer, Constipation | Phase 4 | Status: TERMINATED | Results posted: 2019-03-05